Command Palette

Search for a command to run...

Clinical Trials · NCT01507272

Safety and Tolerability of Liraglutide in Healthy Male Volunteers

CompletedPhase 1Liraglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
34
Start date
Mar 1999
Locations
1 site, United Kingdom
Primary endpoint
AUC (area under the curve)
View Liraglutide compound reference